ACTG vs CVS · rev $285.2M vs P/E 16, rev $402.07B
Acacia Research Corporation (ACTG) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Acacia Research Corporation (ACTG) is a business equipment & supplies company listed on NASDAQ.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported ACTG revenue for 2025-12-31 was $285.2M. Net income was $21.7M. Revenue was up 133.2% from 2024-12-31 to 2025-12-31. ACTG currently screens at market cap $452.0M.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
ACTG currently screens at market cap $452.0M. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the ACTG and CVS stock pages for the full models.
Not investment advice.